Altair Medical announced that it won FDA breakthrough device designation for its Respmeter wearable biosensor device for opioid-induced respiratory depression (OIRD).
Glasgow, Scotland–based Altair Medical’s Respmeter is a chest-worn wireless sensor designed to detect OIRD, a common side effect of using opioid drugs.
The Respmeter monitors and analyzes respiratory patterns by using proprietary algorithms. Once OIRD is detected, the system sends a message to designated first responders or emergency services who can intervene to administer naloxone, which can revive the person within seconds.